Inventor

Stefano Crosignani

Inventor
Nivelles, BE

Overview

22→
Patents
2011–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes22%
C07CAcyclic or carbocyclic compounds5%
Y02ATechnologies for adaptation to climate change5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides2%
PatentTitleYear
10,995,1012-oxo-thiazole derivatives as A2A inhibitors and compounds for use in the treatment of cancers202110,945,994Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body202110,544,0953-indol substituted derivatives, pharmaceutical compositions and methods for use202010,398,679Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors20199,949,951Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors20189,873,6903-indol substituted derivatives, pharmaceutical compositions and methods for use20189,758,505'3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use'20179,688,702'Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors'20179,603,836'Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors'20179,567,320'Pyridazinone-amides derivatives'20179,216,991'Pyrimidine pyrazolyl derivatives'20159,150,519'6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis'20159,126,984'4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use'20159,073,892'Indazolyl triazol derivatives'20158,815,919'Oxadiazole derivatives'20148,802,704'Oxadiazole derivatives'20148,399,448'6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis'20138,273,769'Phenoxy acetic acid derivatives'20128,247,437'N-hydroxyamide derivatives and use thereof'20128,236,963'Tricyclic spiro derivatives as CRTH2 modulators'20128,202,865'Oxadiazole derivatives'20128,008,302'N-hydroxyamide derivatives and use thereof'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2015Patents assigned to MERCK SERONO SA (10)· patent assignee history
2011–2015Based in Saint Genis Pouilly, FR· patent location history
2012–2015Patents assigned to CROSIGNANI STEFANO (8)· patent assignee history
2012–2013Patents assigned to BOMBRUN AGNES (3)· patent assignee history
2012–2015Patents assigned to JORAND-LEBRUN CATHERINE (3)· patent assignee history
2015–2021Patents assigned to ITEOS THERAPEUTICS (8)· patent assignee history
2015–2021Based in Nivelles, BE· patent location history
2021Based in Gosselies, BE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SERONO SA102011–2015
CROSIGNANI STEFANOself82012–2015
ITEOS THERAPEUTICS82015–2021
BOMBRUN AGNES32012–2013
JORAND-LEBRUN CATHERINE32012–2015
Locations
LocationPatentsSpan
Nivelles, BE112015–2021
Saint Genis Pouilly, FR102011–2015
Gosselies, BE12021